Novel Nonpeptide CCK-B Antagonists:  Design and Development of Quinazolinone Derivatives as Potent, Selective, and Orally Active CCK-B Antagonists

Author:

Padia Janak K.1,Field Mark1,Hinton Joanna1,Meecham Ken1,Pablo Julius1,Pinnock Rob1,Roth Bruce D.1,Singh Lakhbir1,Suman-Chauhan Nirmala1,Trivedi Bharat K.1,Webdale Louise1

Affiliation:

1. Departments of Chemistry and of Pharmacokinetics and Drug Metabolism, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48105, and Parke-Davis Neuroscience Research Centre, Cambridge University Fotvie Site, Robinson Way, Cambridge CB2 2QB, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference33 articles.

1. (a) Preliminary accounts of this work were presented at the 211th National ACS Meeting in New Orleans, LA, 1996.

2. (b) Padia, J. K. Novel heterocycles as cholecystokinin (CCK) ligands. International Patent Application No. WO 96/20178.

3. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system

4. Distinct cholecystokinin receptors in brain and pancreas.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3